Flavia Ferrantelli

9PUBLICATIONS
14CO-AUTHORS
Animal protection (incl. pests and pathogens)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyElectrical energy generation (incl. renewables, excl. photovoltaics)Neural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV Proteins.

|Sep 28, 2023
SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.

Flavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini

|Jul 27, 2022
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.

Francesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli

|Feb 26, 2022
Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice.

Flavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi

|Jun 02, 2021
Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles.

Flavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini

|Apr 30, 2021
The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.

Chiara Chiozzini, Francesco Manfredi, Flavia Ferrantelli

Pageof 2

Frequent Collaborators

8 joint publications

Chiara Chiozzini

7 joint publications

Francesco Manfredi

7 joint publications

Maurizio Federico

2 joint publications

Luisa Accardi